Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. 1985

W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij

A quantitative immunoblotting assay (QIBA) for the determination of specific antibody titres in human autoimmune sera is described. In this assay, a total HeLa nuclear protein fraction, immobilized on nitrocellulose blot strips, was used as source of antigens and immunoreactive species of autoantibodies were quantitated by an enzyme linked second antibody procedure. Besides being more discriminative, QIBA appeared to be up to 500 times more sensitive than immunodiffusion or immunoelectrophoresis. In this study we used 21 sera from patients with SLE or MCTD for a quantitative analysis of their specific autoantibody content. Within this group, a very diverse spectrum of antibody populations was observed; anti-RNP sera appeared to contain, among others, high tired antibody versus 70K and 31K polypeptides while all (n = 6) anti-Sm sera recognized a 25kD protein doublet. In a follow-up study of two MCTD patients significant flares in specific antibody content could be observed.

UI MeSH Term Description Entries
D007158 Immunologic Techniques Techniques used to demonstrate or measure an immune response, and to identify or measure antigens using antibodies. Antibody Dissociation,Immunologic Technic,Immunologic Technics,Immunologic Technique,Immunological Technics,Immunological Techniques,Technic, Immunologic,Technics, Immunologic,Technique, Immunologic,Techniques, Immunologic,Antibody Dissociations,Dissociation, Antibody,Dissociations, Antibody,Immunological Technic,Immunological Technique,Technic, Immunological,Technics, Immunological,Technique, Immunological,Techniques, Immunological
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008947 Mixed Connective Tissue Disease A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. Connective Tissue Disease, Mixed,Sharp Syndrome,MCTD,Syndrome, Sharp
D003101 Collodion A nitrocellulose solution in ether and alcohol. Collodion has a wide range of uses in industry including applications in the manufacture of photographic film, in fibers, in lacquers, and in engraving and lithography. In medicine it is used as a drug solvent and a wound sealant. Nitrocellulose,Celloidin,Cellulose Nitrate,Collodion Cotton,Pyroxylin,Cotton, Collodion,Nitrate, Cellulose
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
January 1989, Revue du rhumatisme et des maladies osteo-articulaires,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
January 1985, Scandinavian journal of rheumatology. Supplement,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
December 1988, Israel journal of medical sciences,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
February 2005, Autoimmunity,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
May 2002, Cellular and molecular biology (Noisy-le-Grand, France),
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
July 2005, Nihon rinsho. Japanese journal of clinical medicine,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
February 1982, Israel journal of medical sciences,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
November 1983, Journal of immunological methods,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
August 1990, Zhonghua nei ke za zhi,
W J Habets, and D J de Rooij, and M H Hoet, and L B van de Putte, and W J van Venrooij
January 1994, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,
Copied contents to your clipboard!